Cell Chemical Biology

Papers
(The TQCC of Cell Chemical Biology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Antisense-mediated senseful regulation of orchestrated metabolic response121
New sheriff in town: Cyclic peptide inhibitors of a DUB module116
CBLs downregulation foretells T cell ubiquitination leading to autoimmunity87
Therapeutic potential of inhibiting the PI3Kγ complex for leukemia80
Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 179
A versatile residue numbering scheme for Nav and Cav channels77
Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance76
Advances in spatial proteomics: Mapping proteome architecture from protein complexes to subcellular localizations72
Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples71
A covalent inhibitor targeting Cys16 on RhoA in colorectal cancer70
Heterologous characterization of mechercharmycin A biosynthesis reveals alternative insights into post-translational modifications for RiPPs70
Voices: Challenges and opportunities in regulating the immune system69
Meet the Authors: Christopher R. Mansfield and Emily R. Derbyshire69
Next steps for targeted protein degradation66
RENBP inhibition amplifies metabolic glycan labeling efficiency of antigen-presenting cells in vitro and in vivo66
Control of topoisomerase II activity and chemotherapeutic inhibition by TCA cycle metabolites66
A genome-wide CRISPR-Cas9 screen identifies CENPJ as a host regulator of altered microtubule organization during Plasmodium liver infection65
Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation64
2′-OH as a universal handle for studying intracellular RNAs62
Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development60
Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine59
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas58
FADS2-dependent fatty acid desaturation dictates cellular sensitivity to ferroptosis and permissiveness for hepatitis C virus replication56
Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions55
Meet the Authors: Harkamal S. Jhajj and Peter M. Tessier54
Meet the Cell Chemical Biology author and newest advisory board member: Marcus Conrad53
A complex puzzle: Regulation of SLFN12 RNase activity by phosphorylation50
Peptide-mediated inhibition of the transcriptional regulator Elongin BC induces apoptosis in cancer cells50
Catalytic spike antibodies: A new paradigm in neutralization49
Real-time non-invasive fluorescence imaging of gut commensal bacteria to detect dynamic changes in the microbiome of live mice49
Valence and avidity determine the agonistic activity of anti-TNFR2 nanobody fusion proteins48
Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy47
PALP: A rapid imaging technique for stratifying ferroptosis sensitivity in normal and tumor tissues in situ46
A synthetic RNA-based biosensor for fructose-1,6-bisphosphate that reports glycolytic flux44
Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration44
A fine-tuned azobenzene for enhanced photopharmacology in vivo42
Probing the binding of interleukin-23 to individual receptor components and the IL-23 heteromeric receptor complex in living cells using NanoBRET41
A potent NLRP3 inhibitor effective against both MCC950-sensitive and -resistant inflammation41
Beyond antibiotic resistance: The whiB7 transcription factor coordinates an adaptive response to alanine starvation in mycobacteria41
N6-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis41
Pharmacological management of disease by overcoming structural adversity40
Metabolic tug-of-war: Microbial metabolism shapes colonization resistance against enteric pathogens40
BLOC-1 and BORC: Complex regulators of endolysosomal dynamics40
A double whammy for KEAP140
The art of designed coiled-coils for the regulation of mammalian cells38
PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication37
Visualizing Staphylococcus aureus pathogenic membrane modification within the host infection environment by multimodal imaging mass spectrometry37
Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges36
Meet the authors: Aayushi Uberoi and Elizabeth A. Grice35
Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation34
Two sides of a co(i)ndensate34
Enabling inclusion and looking ahead34
A new chink in cancer’s armor: Unleashing cell death by selective PP5 inhibition33
SynPull: An advanced method for studying neurodegeneration-related aggregates in synaptosomes using super-resolution microscopy33
Humanized zebrafish as a tractable tool for in vivo evaluation of pro-myelinating drugs33
Engineering ERα degraders with pleiotropic ubiquitin ligase ligands maximizes therapeutic efficacy by co-opting distinct effector ligases33
Emerging biochemical, microbial and immunological evidence in the search for why HLA-B∗27 confers risk for spondyloarthritis32
A structure-specific small molecule inhibits a miRNA-200 family member precursor and reverses a type 2 diabetes phenotype32
Shipworm symbiosis ecology-guided discovery of an antibiotic that kills colistin-resistant Acinetobacter32
Splicing modulators elicit global translational repression by condensate-prone proteins translated from introns32
Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome32
Natural products chlorotonils exert a complex antibacterial mechanism and address multiple targets32
Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria31
Inter- and intra-tumoral ALDH1 heterogeneity in breast cancer identifies therapeutic opportunities for ALDH1A-specific inhibitors31
Behavioral control through the direct, focal silencing of neuronal activity31
Arabinose- and xylose-modified analogs of 2′,3′-cGAMP act as STING agonists30
No acetyl-CoA keeps Plasmodium at bay30
Induced proximity in biology and therapeutics30
HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation30
Targeting ribosomal G-quadruplexes with naphthalene-diimides as RNA polymerase I inhibitors for colorectal cancer treatment30
S-Nitrosylation-mediated dysfunction of TCA cycle enzymes in synucleinopathy studied in postmortem human brains and hiPSC-derived neurons30
Covalent inhibition of ACSL4 alleviates ferroptosis-induced acute liver injury30
Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite30
Characterization of an allosteric inhibitor of fungal-specific C-24 sterol methyltransferase to treat Candida albicans infections29
Capsaicin ameliorates inflammation in a TRPV1-independent mechanism by inhibiting PKM2-LDHA-mediated Warburg effect in sepsis29
Boosting glycolysis to combat fragile bone in type 1 diabetes29
Therapeutic induction of ferroptosis in tumors using PD-L1 targeting antibody nanogel conjugates29
Screening in serum-derived medium reveals differential response to compounds targeting metabolism29
Feel the breeze: Opening the therapeutic window with RIPTACs and induced proximity28
In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferin28
Mo’ m1A, mo’ problems27
Small molecule targeting of transcription-replication conflict for selective chemotherapy27
Meet the authors: Mitchel L. Tepe and Huiqing Zhou27
D-aring to explore: New approaches to gasdermin D targeting27
PCNA degradation exhibits superior pharmacological effects over stoichiometric inhibition27
Selective killing of the human gastric pathogen Helicobacter pylori by mitochondrial respiratory complex I inhibitors26
Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate26
Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators26
Mapping the residue specificities of epigenome enzymes by yeast surface display26
Redox proteomics combined with proximity labeling enables monitoring of localized cysteine oxidation in cells26
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers25
Insights into lysophosphatidylserine recognition and Gα12/13-coupling specificity of P2Y1025
Discovery of a PROTAC degrader for METTL3-METTL14 complex25
How to kill an ERKsome target: PROTACs deliver the deathblow25
Multiple PDE3A modulators act as molecular glues promoting PDE3A-SLFN12 interaction and induce SLFN12 dephosphorylation and cell death25
Structural basis of CD97 activation and G-protein coupling25
Epigenetic fluidity meets phenotypic malleability in intestinal epithelial cells25
Mechanisms and functions of lysosomal lipid homeostasis25
RNATACs: Multispecific small molecules targeting RNA by induced proximity25
Protomer selectivity of type II RAF inhibitors within the RAS/RAF complex25
Plant synthetic genomics: Big lessons from the little yeast25
Discovery and biosynthesis of non-canonical C16-terpenoids from Pseudomonas25
Combined morphological and proteome profiling reveals target-independent impairment of cholesterol homeostasis24
Identifying and antagonizing the interactions between layilin and glycosylated collagens24
A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease24
CRAGE-CRISPR facilitates rapid activation of secondary metabolite biosynthetic gene clusters in bacteria24
The physiological and pathological roles of RNA modifications in T cells24
Screening compound libraries for H2O2-mediated cancer therapeutics using a peroxiredoxin-based sensor24
An N terminomics toolbox combining 2-pyridinecarboxaldehyde probes and click chemistry for profiling protease specificity24
Transient hydroxycholesterol treatment restrains TCR signaling to promote long-term immunity24
Chemoproteomic profiling of substrate specificity in gut microbiota-associated bile salt hydrolases24
Targeting selective E3 ligase for healing cardiac fibrosis23
Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells23
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling23
Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor23
Excited to see you: New imaging approaches to detect ferrous iron in vivo23
The chemistry of electrical signaling in sodium channels from bacteria and beyond23
Integrating inflammatory biomarker analysis and artificial-intelligence-enabled image-based profiling to identify drug targets for intestinal fibrosis23
Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders23
Voices: Challenges and opportunities for bioorthogonal chemistry23
Tools to investigate the cell surface: Proximity as a central concept in glycoRNA biology22
PARP trapping is governed by the PARP inhibitor dissociation rate constant22
Identification of small molecules that strongly inhibit bacterial quorum sensing using a high-throughput lipid vesicle lysis assay22
Targeting VPS41 induces methuosis and inhibits autophagy in cancer cells22
CLK2 and CLK4 are regulators of DNA damage-induced NF-κB targeted by novel small molecule inhibitors22
The dark side of circular RNA, a new driver of genome instability21
Biogenesis and roles of tRNA queuosine modification and its glycosylated derivatives in human health and diseases21
Inhibitors of the ATPase p97/VCP: From basic research to clinical applications21
Accelerating multiplexed profiling of protein-ligand interactions: High-throughput plate-based reactive cysteine profiling with minimal input21
Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer21
Inhibiting GLUTtony in cancer20
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia20
Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation20
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells20
Host-like conditions validate nutrient transport as an antimalarial drug target20
Ligand discovery by activity-based protein profiling20
The liquid lectin array detects compositional glycocalyx differences using multivalent DNA-encoded lectins on phage20
Targeted epigenetic induction of mitochondrial biogenesis enhances antitumor immunity in mouse model20
Quinoline-based compounds can inhibit diverse enzymes that act on DNA20
Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp12019
Phosphorylation barcodes direct biased chemokine signaling at CXCR319
One-pot trimodal mapping of unmethylated, hydroxymethylated, and open chromatin sites unveils distinctive 5hmC roles at dynamic chromatin loci19
Cellular reprogramming by protein degradation: The next frontier in cancer immunotherapy19
Monitoring autophagic flux in vivo revealed its physiological response and significance of heterogeneity in pancreatic beta cells19
MICU1 controls the sensitivity of the mitochondrial Ca2+ uniporter to activators and inhibitors19
The culinary chemist: Out of the lab and into the tent19
Meet the authors: Cydney N. Johnson, Shyra Wilde, Elaine Tuomanen, and Jason W. Rosch19
Bortezomib inhibits ZIKV/DENV by interfering with viral polyprotein cleavage via the ERAD pathway19
Naturally occurring three-way junctions can be repurposed as genetically encoded RNA-based sensors19
Small-molecule allosteric inhibitors of GPX419
METTL3: Melting the tumor microenvironment for improved immunotherapy19
A sterol analog inhibits hedgehog pathway by blocking cholesterylation of smoothened18
NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir18
A “light” touch on PI3K to interrogate cancer drug resistance18
In vivo bioluminescence imaging of granzyme B activity in tumor response to cancer immunotherapy18
Clionamines stimulate autophagy, inhibit Mycobacterium tuberculosis survival in macrophages, and target Pik118
Visualization of the dynamic interaction between nucleosomal histone H3K9 tri-methylation and HP1α chromodomain in living cells18
Identification of Pax protein inhibitors that suppress target gene expression and cancer cell proliferation18
Ligand-directed bias of G protein signaling at the dopamine D2 receptor18
Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors18
Targeted degradation of CDK9 potently disrupts the MYC-regulated network18
Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cells18
Strategies of bacterial detection by inflammasomes18
0.075634002685547